NewCa.com: ⚕️ New Ontario Dementia Care Alliance Launches to
- Expert panel to provide proactive, evidence-informed recommendations that are costed and implementable - A panel of 17 leading experts in dementia care
Stay updated with breaking news from Toronto Memory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Expert panel to provide proactive, evidence-informed recommendations that are costed and implementable - A panel of 17 leading experts in dementia care
Eisai has presented and published full data from the Phase 3 clinical trial for its Alzheimer’s disease drug lecanemab, with results showing a statistically significant slowing decline associated with the neurodegenerative disorder. While an accelerated approval decision is expected in early 2023, the latest trial data are key because they represent the confirmatory study that could support an application for full FDA approval.
/CNW/ - Research out of the University of Southern California released yesterday, World Alzheimer's Day, found that Ontario could save up to $9.9 billion in...
A virtual event is coming up on Thursday, to highlight Alzheimer's Awareness month. Debbie Burns the Program C...